Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients.
Morena
M
M
Department of Biochemistry, Lapeyronie University Hospital, Montpellier, France.
Vela
C
C
Garrigue
V
V
Catanzano
J
J
Descomps
B
B
Cristol
J P
JP
Mourad
G
G
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D065095:Calcineurin Inhibitors; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D016559:Tacrolimus / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D008077:Lipoproteins, LDL; D014280:Triglycerides; C099252:oxidized low density lipoprotein; D016572:Cyclosporine; D002784:Cholesterol; D001379:Azathioprine; D016559:Tacrolimus